MedTrace Logo

Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method

NCT05837208 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2023-05-03

No results posted yet for this study

Summary

The aim of the study is to determine:

* the thickness of the RV4369A truly applied on different areas of the face after single application of the product determined by a multispectral imaging method.
* the influence of a second application of the product 15 to 30 minutes after the first application on the product thickness determined by multispectral imaging method.
* the influence of the recommendations of use provided to the subjects before application of the product on the product thickness determined by multispectral imaging method .

Conditions

  • Sunscreen

Interventions

OTHER

RV4369A cosmetic product

The product is applied 1 or 2 times during the 2 study visits. The product is recovered by the technician after application of the product by the volunteer. Application modalities: Inclusion Assessment: The study product is given to the volunteer who applies it to his face (forehead) according to his usual habits. After a waiting time and Multispectral camera measurements, the study product is again applied by the volunteer to his face according to his usual habits. Final assessment: The study product is applied by the Clinical Research Technician on the subject's forearm on 4 delimited areas at specific quantities. After a waiting period and Multispectral camera measurements on the forearm areas, the study product is given to the volunteer who applies it on his face according to the recommendations of use provided by the Technician.

Sponsors & Collaborators

  • Pierre Fabre Dermo Cosmetique

    lead INDUSTRY

Principal Investigators

  • Thérèse Nocera, MD · Pierre Fabre Dermo Cosmetique

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-04
Primary Completion
2022-04-29
Completion
2022-04-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05837208 on ClinicalTrials.gov